 | Thu. Dec. 15, 2011 A Market Basket to anchor Cornerstone Square in Westford
A Market Basket supermarket will anchor Cornerstone Square, a shopping center planned for Westford, said the project’s developer, RA Ventures. RA Ventures said it recently broke ground on the project, and Cornerstone Square’s grand opening is scheduled for fall 2012. Plans call for the roughly 240,000-square foot project to have about 190,000 square feet of retail space; much of the remaining footage is being set aside for medical office space. State: Many Mass. store price scanners deficient
A survey has found problems with many price scanners located in the aisles of Massachusetts retail stores. The state’s Division of Standards said today that it inspected 433 scanners in 47 stores and nearly half were unable to provide a price tag or a means for attaching the price tag to a product. Under Massachusetts regulations, stores do not have to put price stickers on non-food items if they have a sufficient number of scanners that can display prices. But Mass. workplace fatalities fell last year
There were 51 fatal work injuries in Massachusetts in 2010, the lowest total for the state since 2002, according to a preliminary count by the US Bureau of Labor Statistics. The most frequent fatal event was a fall, the bureau added; in 2009, there were 64 workplace fatalities in Massachusetts. For all of New England, a total of 146 fatal work injuries were reported regionwide in 2010, up from 139 in 2009, the bureau said. An increase in Connecticut was one reason why the regional total rose. Cerulean Pharma closes $15m Series D financing
Cerulean Pharma Inc., a Cambridge company focused on nanopharmaceuticals, said it has closed a $15 million Series D financing. The round included participation from new investor, CVF LLC, an affiliate of Henry Crown and Co. of Chicago, as well as full participation from all other existing investors, including Polaris Venture Partners, Venrock, Lilly Ventures, Lux Capital, and Bessemer Venture Partners. Cerulean is working on a drug candidate that would treat non-small cell lung cancer. At 7 % for Nov., Mass. unemployment falls to lowest rate in nearly three years
The Massachusetts unemployment rate last month fell to its lowest rate in nearly three years as employers added jobs for the second consecutive month, the state Executive Office of Labor and Workforce Development reported today. The state unemployment rate fell to 7 percent last month, from 7.3 percent in October. It was the lowest rate since December 2008. The national unemployment rate was 8.6 percent last month. Massachusetts employers added 5,000 jobs in November, after adding nearly 12,000 in October. IBM to buy Emptoris
Technology giant IBM said today that it has agreed to buy Emptoris Inc., a Burlington-based provider of cloud analytics software that helps companies make thier supply-chain operations more efficient. Financial terms were not disclosed. This will be IBM’s 20th acquisition of a Massachusetts-based company since 2003. Jeffrey Leiden will head Vertex, which gets priority review for cystic fibrosis drug candidate
Vertex Pharmaceuticals Inc., in a surprise move, this morning said its chief executive Matthew Emmens will step down Feb. 1 and be replaced by Jeffrey Leiden, who has been a Vertex director since mid-2009. The transition comes as Cambridge-based Vertex, which won Food and Drug Administration approval last spring to sell a drug to treat hepatitis C, stands on the verge of another business breakthrough. Vertex said today that the FDA has granted priority review of its new drug application for Kalydeco, a treatment for cystic fibrosis. Siena survey: Many locals believe America’s best days are behind us
According to a new poll from the Siena Research Institute, 49 percent of Massachusetts residents now believe that “our country’s best economic days are behind us and that the next generation will have to accept a lower standard of living.” On the flip-side, 46 percent of Massachusetts respondents said that the current economic problems are temporary and that the country will return to financial health. Survey results were based on random telephone calls to 634 adult Massachusetts residents between late October and early December. Third Rock Ventures launches Ember Therapeutics
Third Rock Ventures LLC, a venture capital firm with offices in Boston, announced the formation of Ember Therapeutics with a $34 million Series A financing. In a press release, Ember said it looks to leverage findings in brown-fat biology and recent breakthroughs in selective insulin sensitivity to develop treatments for metabolic diseases, including Type 2 diabetes and obesity. Ember’s interim chief executive is Louis Tartaglia, a partner at Third Rock Ventures. Mass. ranked low in report on corporate subsidies
Massachusetts ranked low --- 43 out of 51 --- in a report card that looked to evaluate the benefits that states and the District of Columbia reap from granting corporate tax breaks. The report card is from a group called Good Jobs First, which says subsidies should be used to create jobs and reduce unemployment. The Patrick administration responded that the Massachusetts economy has recovered faster than the nation’s and that its unemployment rate is lower the national rate. Pinnacle Awards honor local women leaders
The Greater Boston Chamber of Commerce today announced the winners of its 2012 Pinnacle Awards, which honor women for workplace achievement, leadership, and a commitment to enhance the quality of life in the region. Rosabeth Moss Kanter, a professor at Harvard Business School, will receive a lifetime achievement award. Others being honored include chief executive Suzanne Bates of Bates Communications Inc.; Marcy L. Reed, president of National Grid’s Massachusetts operations; US District Attorney Carmen M. Ortiz; and Mary Jo Meisner, a Boston Foundation vice president. |
No comments:
Post a Comment